K-Raman Purushothaman1, Meerarani Purushothaman2, Irene C Turnbull2, David H Adams3, Anelechi Anyanwu3, Prakash Krishnan2, Annapoorna Kini2, Samin K Sharma2, William N O'Connor4, Pedro R Moreno2. 1. The Zena and Michael A. Weiner Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Department of Medicine. Electronic address: purushothaman.kothandaraman@mountsinai.org. 2. The Zena and Michael A. Weiner Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Department of Medicine. 3. Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, NY. 4. Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA.
Abstract
BACKGROUND: Collagen cross-linking is mediated by lysyl oxidase (LOX) enzyme in the extracellular matrix (ECM) of mitral valve leaflets. Alterations in collagen content and LOX protein expression in the ECM of degenerative mitral valve may enhance leaflet expansion and disease severity. METHODS: Twenty posterior degenerative mitral valve leaflets from patients with severe mitral regurgitation were obtained at surgery. Five normal posterior mitral valve leaflets procured during autopsy served as controls. Valvular interstitial cells (VICs) density was quantified by immunohistochemistry, collagen Types I and III by picro-sirius red staining and immunohistochemistry, and proteoglycans by alcian blue staining. Protein expression of LOX and its mediator TGFβ1 were quantified by immunofluorescence and gene expression by PCR. RESULTS: VIC density was increased, structural Type I collagen density was reduced, while reparative Type III collagen and proteoglycan densities were increased (P<.0001) with an increase in spongiosa layer thickness in myxomatous valves. These changes were associated with a reduction in LOX (P<.0001) and increase in TGFβ1 protein expression (P<.0001). However, no significant change was seen in gene expression. Linear regression analysis identified a correlation between Type I collagen density and LOX grade (R2=0.855; P<.0001). CONCLUSIONS: Reduced Type I collagen density with a simultaneous increase in Type III collagen and proteoglycan densities possibly contributes to spongiosa layer expansion resulting in incompetent mitral valve leaflets. Observed changes in Type I and III collagen densities in Degenerative Mitral Valve Disease may be secondary to alterations in LOX protein expression, contributing to disorganization of ECM and disease severity.
BACKGROUND: Collagen cross-linking is mediated by lysyl oxidase (LOX) enzyme in the extracellular matrix (ECM) of mitral valve leaflets. Alterations in collagen content and LOX protein expression in the ECM of degenerative mitral valve may enhance leaflet expansion and disease severity. METHODS: Twenty posterior degenerative mitral valve leaflets from patients with severe mitral regurgitation were obtained at surgery. Five normal posterior mitral valve leaflets procured during autopsy served as controls. Valvular interstitial cells (VICs) density was quantified by immunohistochemistry, collagen Types I and III by picro-sirius red staining and immunohistochemistry, and proteoglycans by alcian blue staining. Protein expression of LOX and its mediator TGFβ1 were quantified by immunofluorescence and gene expression by PCR. RESULTS: VIC density was increased, structural Type I collagen density was reduced, while reparative Type III collagen and proteoglycan densities were increased (P<.0001) with an increase in spongiosa layer thickness in myxomatous valves. These changes were associated with a reduction in LOX (P<.0001) and increase in TGFβ1 protein expression (P<.0001). However, no significant change was seen in gene expression. Linear regression analysis identified a correlation between Type I collagen density and LOX grade (R2=0.855; P<.0001). CONCLUSIONS: Reduced Type I collagen density with a simultaneous increase in Type III collagen and proteoglycan densities possibly contributes to spongiosa layer expansion resulting in incompetent mitral valve leaflets. Observed changes in Type I and III collagen densities in Degenerative Mitral Valve Disease may be secondary to alterations in LOX protein expression, contributing to disorganization of ECM and disease severity.
Authors: K-Raman Purushothaman; Meerarani Purushothaman; Paul Muntner; Patrick A Lento; William N O'Connor; Samin K Sharma; Valentin Fuster; Pedro R Moreno Journal: Vasc Med Date: 2011-04 Impact factor: 3.239
Authors: K-Raman Purushothaman; Meerarani Purushothaman; Andrew P Levy; Patrick A Lento; Solene Evrard; Jason C Kovacic; Karen C Briley-Saebo; Sotirios Tsimikas; Joseph L Witztum; Prakash Krishnan; Annapoorna Kini; Zahi A Fayad; Valentin Fuster; Samin K Sharma; Pedro R Moreno Journal: J Am Coll Cardiol Date: 2012-07-10 Impact factor: 24.094
Authors: O Busnadiego; D Gorbenko Del Blanco; J González-Santamaría; J P Habashi; J F Calderon; P Sandoval; D Bedja; J Guinea-Viniegra; M Lopez-Cabrera; T Rosell-Garcia; J M Snabel; R Hanemaaijer; A Forteza; H C Dietz; G Egea; F Rodriguez-Pascual Journal: J Mol Cell Cardiol Date: 2015-05-16 Impact factor: 5.000
Authors: K Jane Grande-Allen; Brian P Griffin; Norman B Ratliff; Delos M Cosgrove; Ivan Vesely Journal: J Am Coll Cardiol Date: 2003-07-16 Impact factor: 24.094
Authors: Cristina Rodríguez; José Martínez-González; Berta Raposo; Javier F Alcudia; Anna Guadall; Lina Badimon Journal: Cardiovasc Res Date: 2008-05-09 Impact factor: 10.787
Authors: José González-Santamaría; María Villalba; Oscar Busnadiego; Marina M López-Olañeta; Pilar Sandoval; Jessica Snabel; Manuel López-Cabrera; Janine T Erler; Roeland Hanemaaijer; Enrique Lara-Pezzi; Fernando Rodríguez-Pascual Journal: Cardiovasc Res Date: 2015-08-10 Impact factor: 10.787